Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph II CD24Fc for Prevention of Acute GVHD Following Myeloablative Allogeneic HSCT

Protocol: OSU-15286

Full Title

A Phase II Trial of CD24Fc for Prevention of Acute Graft-versus-Host Disease Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplant